See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348911_2023_KalVista_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001348911, KalVista Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 193,647,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,178,000 |
| 3 | remainder_Assets | 8,055,000 |
| 4 | LiabilitiesCurrent | 11,576,000 |
| 5 | LiabilitiesNoncurrent | 7,211,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,446,000 |
| 9 | ResearchAndDevelopmentExpense | 70,167,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 14,274,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,429,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 203,880,000 |
| 1 | Liabilities | 18,787,000 |
| 2 | Expenses | 96,613,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 185,093,000 |
| 5 | NetIncome | -82,339,000 |
| 6 | ComprehensiveNetIncome | -83,553,500 |
| 7 | BaseVar | 167,991,500 |
| 8 | EconomicCapitalRatio | 2.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
